Results 251 to 260 of about 444,077 (311)

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Insights From a User Experience-Focused Virtual Study on the Feasibility and Challenges of Decentralized Clinical Trials. [PDF]

open access: yesClin Transl Sci
Ma Y   +14 more
europepmc   +1 more source

Assessing the User Experience of the EU Mobile App for Cancer Prevention: Mixed Methods Study. [PDF]

open access: yesJMIR Form Res
Ahmed F   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy